Prevalence of Electrolyte Imbalance in Chronic Kidney Disease:A Study at Tertiary Care Hospital in South Punjab,Pakistan

November 25, 2019 updated by: Hafiz Muhammad Attaullah, Islamia University of Bahawalpur

Prevalence of Electrolyte Imbalance in Chronic Kidney Disease: A Study at Tertiary Care Hospitals in South Punjab, Pakistan

an observational cross-sectional study is done to calculate the electrolyte imbalance at different stages of chronic kidney disease at tertiary care hospital.

Study Overview

Status

Unknown

Conditions

Detailed Description

an observational cross-sectional study is done to calculate the electrolyte imbalance at different stages of chronic kidney disease at tertiary care hospitals of south Punjab, Pakistan .The outcomes of chronic kidney disease and end stage of renal failure will be calculated according to standard protocol. Under the supervision of pathologists, pharmacologists, pharmacists, nephrologists, urologists and biostatistician. The standard protocol was authorized by ethical committee of each center. patient consent form was

Study Type

Observational

Enrollment (Anticipated)

385

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Pakistan
    • Punjab
      • Bahāwalpur, Punjab, Pakistan, 63100
        • Recruiting
        • Faculty of Pharmacy and Alternative Medicine Khawaja Freed Campus
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

An observational cross sectional study is done on pakistani population while working in different tertiary care hospitals of south Punjab including Bahawal Victoria hospital Bahawalpur, kidney center Multan and many registered clinics, under the supervision of pathologists, pharmacologists,pharmacists,nephrologists,urologists and biostatistician.

Description

Inclusion Criteria:

  • CKD patients ranging
  • age from 20-80
  • dialysis and pre-dialysis patients
  • who provide written consent form

Exclusion Criteria:

  • congenital one kidney patients
  • organ or kidney donors and transplantation
  • pregnant women
  • renal injury during trauma

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
patients of chronic kidney disease
no interventions

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Serum potassium in mEq/L
Time Frame: 2days
Serum potassium in mEq/L by taking blood sample under standard condition
2days
serum urea in mg/dl
Time Frame: 2days
serum urea in mg/dl by taking blood sample under standard condition
2days
Serum creatinine in mg/dl
Time Frame: 2days
Serum creatinine in mg/dl by taking blood sample under standard condition
2days
Serum calcium in mg/dl
Time Frame: 2days
Serum calcium in mg/dl by taking blood sample under standard condition
2days
Serum sodium in mEq/L
Time Frame: 2days
Serum sodium in mEq/L by taking blood sample under standard condition
2days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood pressure in mm of Hg
Time Frame: 2days
Blood pressure in mm of Hg
2days
Blood glucose concentration in mg/dl
Time Frame: 2days
Blood glucose concentration in mg/dl random
2days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Islamia University of Bahawalpur

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2018

Primary Completion (Actual)

November 25, 2019

Study Completion (Anticipated)

November 25, 2019

Study Registration Dates

First Submitted

January 13, 2019

First Submitted That Met QC Criteria

January 13, 2019

First Posted (Actual)

January 16, 2019

Study Record Updates

Last Update Posted (Actual)

November 26, 2019

Last Update Submitted That Met QC Criteria

November 25, 2019

Last Verified

November 1, 2019

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IslamiaUS

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Kidney Diseases

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe